Nasser Rakhshani

Nasser Rakhshani

Auto-generated profile, based on publicly available information

Nasser Rakhshani

Gastrointestinal and Liver Diseases Research Center, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2009 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
APAkram Pourshams
Akram Pourshams
HKHooman Khademi
Hooman Khademi
AMAkbar Fazeltabar Malekshah
Akbar Fazeltabar Malekshah
FIFarhad Islami
Farhad Islami
MNMehdi Nouraei
Mehdi Nouraei
RMReza Malekzadeh
Reza Malekzadeh
The earliest reports of high incidence of oesophageal cancer (OC) in the northern parts of Iran date back to the early 1970s.1,2 A population-based cancer registry was established in 1969 as a joint effort between Tehran University and the International Agency for Research on Cancer (IARC). This registry confirmed the high incidence of OC in the eastern portion of the Caspian Sea littoral, in the area that is now known as Golestan Province. The highest incidence rates were reported from the semi-desert plain settled mainly by people of Turkmen ethnicity in Gonbad and Kalaleh counties, with estimated incidence rates of 109/105 among men and 174/105 among women (adjusted to the 1970 World Standard Population).3 The registry also showed low incidence of OC in the nearby Gilan province, 300 km to the west of Golestan, with incidence rates of 15/105 and 5.5/105 among men and women, respectively. A series of studies were conducted in the region in the 1970s, but they were not conclusive in explaining the very high rates. However, they pointed to several factors, including: (i) a diet deficient in fruits and vegetables;4 (ii) low socio-economic status; (iii) thermal injury from consumption of very hot tea;5 and (iv) carcinogen exposure from lifestyle factors including opium consumption.6–8 The high incidence of OC in Golestan was confirmed by a recent screening study.9

8 February 2006 in European Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
AMA F Malekshah
A F Malekshah
MKM Kimiagar
M Kimiagar
MSM Saadatian-Elahi
M Saadatian-Elahi
APA Pourshams
A Pourshams
MNM Nouraie
M Nouraie
RMReza Malekzadeh
Reza Malekzadeh
Background: A pilot study was carried out to evaluate validity and reproducibility of a food frequency questionnaire (FFQ), which was designed to be used in a prospective cohort study in a population at high risk for esophageal cancer in northern Iran. Methods: The FFQ was administered four times to 131 subjects, aged 35–65 years, of both sexes. Twelve 24-h dietary recalls for two consecutive days were administered monthly during 1 year and used as a reference method. The excretion of nitrogen was measured on four 24-h urine samples, and plasma levels of β-carotene, retinol, vitamin C and α-tocopherol was measured from two time points. Relative validity of FFQ and 24-h diet recall was assessed by comparing nutrient intake derived from both methods with the urinary nitrogen and plasma levels of β-carotene, retinol, vitamin C and α-tocopherol. Results: Correlation coefficients comparing energy and nutrients intake based on the mean of the four FFQ and the mean of twelve 24-h diet recalls were 0.75 for total energy, 0.75 for carbohydrates, 0.76 for proteins and 0.65 for fat. Correlation coefficients between the FFQ-based intake and serum levels of β-carotene, retinol, vitamin C and vitamin E/α-tocopherol were 0.37, 0.32, 0.35 and 0.06, respectively. Correlation coefficients between urinary nitrogen and FFQ-based protein intake ranged from 0.23 to 0.35. Intraclass correlation coefficients used to measure reproducibility of FFQ ranged from 0.66 to 0.89. Conclusion: We found that the FFQ provides valid and reliable measurements of habitual intake for energy and most of the nutrients studied.

26 October 2007 in Gut
Verified
Journal Article
Closed access
PDF file
MDMohammad Derakhshan
Mohammad Derakhshan
RMReza Malekzadeh
Reza Malekzadeh
HWH Watabe
H Watabe
AYA Yazdanbod
A Yazdanbod
VFV Fyfe
V Fyfe
KMK E L McColl
K E L McColl
Introduction: Atrophic gastritis is a risk factor for non-cardia gastric cancer, and gastro-oesophageal reflux disease (GORD) for oesophageal adenocarcinoma. The role of atrophic gastritis and GORD in the aetiology of adenocarcinoma of the cardia remains unclear. We have investigated the association between adenocarcinoma of the different regions of the upper gastrointestinal tract and atrophic gastritis and GORD symptoms. Methods: 138 patients with upper GI adenocarcinoma and age- and sex-matched controls were studied. Serum pepsinogen I/II was used as a marker of atrophic gastritis and categorised to five quintiles. History of GORD symptoms, smoking and H pylori infection were incorporated in logistic regression analysis. Lauren classification of gastric cancer was used to subtype gastric and oesophageal adenocarcinoma. Results: Non-cardia cancer was associated with atrophic gastritis but not with GORD symptoms; 55% of these cancers were intestinal subtype. Oesophageal adenocarcinoma was associated with GORD symptoms, but not with atrophic gastritis; 84% were intestinal subtype. Cardia cancer was positively associated with both severe gastric atrophy [OR, 95% CI: 3.92 (1.77 to 8.67)] and with frequent GORD symptoms [OR, 95% CI: 10.08 (2.29 to 44.36)] although the latter was only apparent in the non-atrophic subgroup and in the intestinal subtype. The association of cardia cancer with atrophy was stronger for the diffuse versus intestinal subtype and this was the converse of the association observed with non-cardia cancer. Conclusion: These findings indicate two distinct aetiologies of cardia cancer, one arising from severe atrophic gastritis and being of intestinal or diffuse subtype similar to non-cardia cancer, and one related to GORD and intestinal in subtype, similar to oesophageal adenocarcinoma. Gastric atrophy, GORD symptoms and histological subtype may distinguish between gastric versus oesophageal origin of cardia cancer.

1 April 2003 in Journal of Hepatology
Verified
Journal Article
Closed access
SMShahin Merat
Shahin Merat
RMReza Malekzadeh
Reza Malekzadeh
MSMasoud Reza Sohrabi
Masoud Reza Sohrabi
MSMasoud Sotoudeh
Masoud Sotoudeh
NRNasser Rakhshani
Nasser Rakhshani
SNSiavosh Naserimoghadam
Siavosh Naserimoghadam

14 December 2004 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
APA Pourshams
A Pourshams
MSM Saadatian-Elahi
M Saadatian-Elahi
MNM Nouraie
M Nouraie
AMA F Malekshah
A F Malekshah
NRN Rakhshani
N Rakhshani
RMReza Malekzadeh
Reza Malekzadeh
To investigate the incidence of oesophageal cancer (EC) in the Golestan province of North-East Iran, we invited 1349 rural and urban inhabitants of Golestan province aged 35–80 to undergo extensive lifestyle interviews and to provide biological samples. The interview was repeated on a subset of 130 participants to assess reliability of questionnaire and medical information. Temperature at which tea was consumed was measured on two occasions by 110 subjects. Samples of rice, wheat and sorghum were tested for fumonisin contamination. An active follow-up was carried out after 6 and 12 months. A total of 1057 subjects (610 women and 447 men) participated in this feasibility study (78.4% participation rate). Cigarette smoking, opium and alcohol use were reported by 163 (13.8%), 93 (8.8%) and 39 (3.7%) subjects, respectively. Tobacco smoking was correlated with urinary cotinine (κ=0.74). Most questionnaire data had κ >0.7 in repeat measurements; tea temperature measurement was reliable (κ=0.71). No fumonisins were detected in the samples analysed. During the follow-up six subjects were lost (0.6%), two subjects developed EC (one dead, one alive); in all, 13 subjects died (with cause of death known for 11, 84.6%). Conducting a cohort study in Golestan is feasible with reliable information obtained for suspected risk factors; participants can be followed up for EC incidence and mortality.

31 October 2008 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
TPTahereh Pirouz
Tahereh Pirouz
LZLeila Zounubi
Leila Zounubi
HKHussein Keivani
Hussein Keivani
NRNasser Rakhshani
Nasser Rakhshani
MHMahshid Hormazdi
Mahshid Hormazdi